Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Sintilimab+Apatinib+Albumin-Bound Paclitaxel(Nab-Paclitaxel)+Carboplatin
Sponsor: Jiuda Zhao